Skip to main content

Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1.

Citation
Hampton, K. K., et al. “Insulin Receptor Plasma Membrane Levels Increased By The Progesterone Receptor Membrane Component 1.”. Molecular Pharmacology, pp. 665-673.
Center Washington University in St Louis
Author Kaia K Hampton, Katie Anderson, Hilaree Frazier, Olivier Thibault, Rolf J Craven
Abstract

The insulin receptor (IR) is a ligand-activated receptor tyrosine kinase that has a key role in metabolism, cellular survival, and proliferation. Progesterone receptor membrane component 1 (PGRMC1) promotes cellular signaling via receptor trafficking and is essential for some elements of tumor growth and metastasis. In the present study, we demonstrate that PGRMC1 coprecipitates with IR. Furthermore, we show that PGRMC1 increases plasma membrane IR levels in multiple cell lines and decreases insulin binding at the cell surface. The findings have therapeutic applications because a small-molecule PGRMC1 ligand, AG205, also decreases plasma membrane IR levels. However, PGRMC1 knockdown via short hairpin RNA expression and AG205 treatment potentiated insulin-mediated phosphorylation of the IR signaling mediator AKT. Finally, PGRMC1 also increased plasma membrane levels of two key glucose transporters, GLUT-4 and GLUT-1. Our data support a role for PGRMC1 maintaining plasma membrane pools of the receptor, modulating IR signaling and function.

Year of Publication
2018
Journal
Molecular pharmacology
Volume
94
Issue
1
Number of Pages
665-673
Date Published
12/2018
ISSN Number
1521-0111
DOI
10.1124/mol.117.110510
Alternate Journal
Mol. Pharmacol.
PMID
29674524
PMCID
PMC5987996
Download citation